The Immune Oncology Research Institute was established in April 2022 by pediatric oncologist and hematologist Gevorg Tamamyan, oncologist Samvel Bardakhchyan and hematologist Astghik Voskanyan.
The founders of IMMONC believe in the importance of international collaboration in research to achieve significant and impactful advancements in cancer care and outcomes.
IMMONC has gathered a dedicated team of researchers to realize its goals. We are determined to grow and make a difference in the lives of cancer patients and their loved ones.
The mission of the Immune Oncology Research Institute is to advance research that can help prevent, treat, and cure cancer and make them available for beneficiaries.
• To advance cancer knowledge and care through breakthrough scientific research
• To integrate innovative immune-oncology therapies into clinical practice for different types of cancers
• To generate and collect clinical data for the identification of new therapeutic targets, developing predictive models and optimizing patient outcomes
• To increase the availability and accessibility of those discoveries for cancer patients
• To create a world-class professional environment and to attract the brightest minds in the cancer field
• To train the next generation of leading cancer researchers.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.